Biogen, Inc. (BIIB)
216.78
-1.72
(-0.79%)
USD |
NASDAQ |
Aug 31, 16:00
216.78
0.00 (0.00%)
After-Hours: 20:00
Biogen Cash from Operations (TTM) : 2.879B for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.879B |
| March 31, 2026 | 2.591B |
| December 31, 2025 | 2.205B |
| September 30, 2025 | 2.454B |
| June 30, 2025 | 2.117B |
| March 31, 2025 | 2.582B |
| December 31, 2024 | 2.876B |
| September 30, 2024 | 2.127B |
| June 30, 2024 | 1.784B |
| March 31, 2024 | 1.645B |
| December 31, 2023 | 1.547B |
| September 30, 2023 | 1.360B |
| June 30, 2023 | 1.428B |
| March 31, 2023 | 1.678B |
| December 31, 2022 | 1.384B |
| September 30, 2022 | 2.398B |
| June 30, 2022 | 2.542B |
| March 31, 2022 | 3.033B |
| December 31, 2021 | 3.640B |
| September 30, 2021 | 2.434B |
| June 30, 2021 | 2.810B |
| March 31, 2021 | 3.532B |
| December 31, 2020 | 4.230B |
| September 30, 2020 | 6.557B |
| June 30, 2020 | 7.071B |
| Date | Value |
|---|---|
| March 31, 2020 | 7.086B |
| December 31, 2019 | 7.079B |
| September 30, 2019 | 7.014B |
| June 30, 2019 | 7.055B |
| March 31, 2019 | 6.190B |
| December 31, 2018 | 6.188B |
| September 30, 2018 | 5.811B |
| June 30, 2018 | 5.703B |
| March 31, 2018 | 5.773B |
| December 31, 2017 | 4.551B |
| September 30, 2017 | 4.609B |
| June 30, 2017 | 3.968B |
| March 31, 2017 | 3.794B |
| December 31, 2016 | 4.575B |
| September 30, 2016 | 4.039B |
| June 30, 2016 | 3.947B |
| March 31, 2016 | 3.999B |
| December 31, 2015 | 3.716B |
| September 30, 2015 | 3.609B |
| June 30, 2015 | 3.627B |
| March 31, 2015 | 3.571B |
| December 31, 2014 | 2.942B |
| September 30, 2014 | 2.878B |
| June 30, 2014 | 2.636B |
| March 31, 2014 | 2.271B |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Ionis Pharmaceuticals, Inc. | -496.43M |
| AbbVie, Inc. | 19.51B |
| Regeneron Pharmaceuticals, Inc. | 4.681B |
| Vertex Pharmaceuticals, Inc. | 4.293B |
| Amgen, Inc. | 12.48B |